The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study
- PMID: 23186910
- PMCID: PMC3508199
- DOI: 10.1136/bmj.e7895
The spectrum of thyroid disease and risk of new onset atrial fibrillation: a large population cohort study
Abstract
Objectives: To examine the risk of atrial fibrillation in relation to the whole spectrum of thyroid function in a large cohort of patients.
Design: Population based cohort study of general practice patients identified by linkage of nationwide registries at the individual level.
Setting: Primary care patients in the city of Copenhagen.
Subjects: Registry data for 586,460 adults who had their thyroid function evaluated for the first time by their general practitioner during 2000-10 and who were without previously recorded thyroid disease or atrial fibrillation.
Main outcome measure: Poisson regression models used to estimate risk of atrial fibrillation by thyroid function.
Results: Of the 586,460 individuals in the study population (mean (SD) age 50.2 (16.9) years, 39% men), 562,461 (96.0%) were euthyroid, 1670 (0.3%) had overt hypothyroidism, 12,087 (2.0%) had subclinical hypothyroidism, 3966 (0.7%) had overt hyperthyroidism, and 6276 (1.0%) had subclinical hyperthyroidism. Compared with the euthyroid individuals, the risk of atrial fibrillation increased with decreasing levels of thyroid stimulating hormone (TSH) from high normal euthyroidism (incidence rate ratio 1.12 (95% CI 1.03 to 1.21)) to subclinical hyperthyroidism with reduced TSH (1.16 (0.99 to 1.36)) and subclinical hyperthyroidism with supressed TSH (1.41 (1.25 to 1.59)). Both overt and subclinical hypothyroidism were associated with a lower risk of atrial fibrillation.
Conclusion: The risk of atrial fibrillation was closely associated with thyroid activity, with a low risk in overt hypothyroidism, high risk in hyperthyroidism, and a TSH level dependent association with risk of atrial fibrillation across the spectrum of subclinical thyroid disease.
Conflict of interest statement
Competing interests: All authors have completed the ICMJE uniform disclosure form at
Figures



Comment in
-
Thyroid function: Thyroid dysfunction and risk of atrial fibrillation.Nat Rev Endocrinol. 2013 Feb;9(2):63. doi: 10.1038/nrendo.2012.239. Epub 2012 Dec 18. Nat Rev Endocrinol. 2013. PMID: 23296162 No abstract available.
-
[Are thyroid disorders a predisposition for atrial fibrillation?].Dtsch Med Wochenschr. 2013 Feb;138(7):296. Dtsch Med Wochenschr. 2013. PMID: 23520616 German. No abstract available.
References
-
- Biondi B, Palmieri EA, Fazio S, Cosco C, Nocera M, Saccà L, et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 2000;85:4701-05. - PubMed
-
- Faber J, Wiinberg N, Schifter S, Mehlsen J. Haemodynamic changes following treatment of subclinical and overt hyperthyroidism. Eur J Endocrinol 2001;145:391-6. - PubMed
-
- Gammage MD, Parle JV, Holder RL, Roberts LM, Hobbs FD, Wilson S, et al. Association between serum free thyroxine concentration and atrial fibrillation. Arch Intern Med 2007;167:928-34. - PubMed
-
- Heeringa J, Hoogendoorn EH, van der Deure WM, Hofman A, Peeters RP, Hop WC, et al. High-normal thyroid function and risk of atrial fibrillation: the Rotterdam study. Arch Intern Med 2008;168:2219-24. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical